{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:26:59Z","timestamp":1782962819645,"version":"3.54.5"},"reference-count":14,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Laboratory Analysis"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Ongoing efforts in the development of <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg detection kits are focused on improving sensitivity and specificity. The purpose of this study was to evaluate an improved, highly sensitive quantitative assay, \u201cLumipulse <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content>\u201d, a chemiluminescent enzyme immunoassay designed for a fully automated instrument, the \u201cLumipulse G1200\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples for reproducibility, dilution, correlation, sensitivity, and specificity studies were obtained from patients at the Osaka University Hospital. Seroconversion and sensitivity panels were purchased from a commercial vender. Subtype, sensitivity panels, and <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg recombinant proteins with one or two amino acid substitutions were prepared in\u2010house.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The coefficients of variation for the low, medium, and high concentration samples ranged from 1.93 to 2.55%. The <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content> reagent for dilution testing showed good linearity in the 0.005\u2010150 <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content> range and no prozone phenomenon. All 102 <jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content> carrier samples were positive by <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content>, while other commercial reagents showed one or more to be negative. In the seroconversion panel, the 14\u2010day blood sample was positive. The sensitivity against <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content> \u201cad\u201d and \u201cay\u201d subtypes was 0.025\u00a0ng\/mL. Comparisons among the <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> HISCL<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">Architect HB<\/jats:styled-content>sAg reagents were performed using the Bland\u2010Altman plot. Specificity for 1000 seronegative individuals was 99.7%. <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content> detected 29 positive serum among 12\u00a0231 routinely obtained serum samples, which showed concentrations of 0.005\u20100.05 <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>According to these results, the Lumipulse <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg\u2010<jats:styled-content style=\"fixed-case\">HQ<\/jats:styled-content> assay, with a highly sensitive limit of detection of 0.005 <jats:styled-content style=\"fixed-case\">IU<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>, may facilitate the development of a better management strategy for a considerable proportion of infected patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcla.22334","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T11:16:39Z","timestamp":1507288599000},"source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of the highly sensitive chemiluminescent enzyme immunoassay \u201cLumipulse <scp>HB<\/scp>sAg\u2010<scp>HQ<\/scp>\u201d for hepatitis B virus screening"],"prefix":"10.1002","volume":"32","author":[{"given":"Matsuo","family":"Deguchi","sequence":"first","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"},{"name":"Division of Infection Control and Prevention Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kagita","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nori","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"},{"name":"Division of Infection Control and Prevention Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Tsukamoto","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"},{"name":"Division of Infection Control and Prevention Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Takao","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Tahara","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuhiro","family":"Maeda","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"},{"name":"Division of Health Science Osaka University Graduate School of Medicine  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[{"name":"The Laboratory for Clinical Investigation Osaka University Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Central Research Laboratories Fujirebio Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Central Research Laboratories Fujirebio Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Miyakoshi","sequence":"additional","affiliation":[{"name":"Clinical Evaluation Group Fujirebio Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0508-9561","authenticated-orcid":false,"given":"Mitsuo","family":"Isomura","sequence":"additional","affiliation":[{"name":"Clinical Evaluation Group Fujirebio Inc.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02390.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24364"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12269"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2003.10.002"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.02026.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21584"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9354-7"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00726-13"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/JCM.38.7.2793-2794.2000","article-title":"Hepatitis B virus surface antigen (HBsAg) mutants in Singapore adults and vaccinated children with high anti\u2010hepatitis B virus antibody levels but negative for HBsAg","volume":"38","author":"Chen WN","year":"2000","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200002)60:2<113::AID-JMV2>3.0.CO;2-0"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.10.008"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.04.010"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2968-2975.2006"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23571"}],"container-title":["Journal of Clinical Laboratory Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcla.22334","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcla.22334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:17:18Z","timestamp":1695471438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcla.22334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1002\/jcla.22334"],"URL":"https:\/\/doi.org\/10.1002\/jcla.22334","archive":["Portico"],"relation":{},"ISSN":["0887-8013","1098-2825"],"issn-type":[{"value":"0887-8013","type":"print"},{"value":"1098-2825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]},"article-number":"e22334"}}